Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.

Kehm RD, Hopper JL, John EM, Phillips KA, MacInnis RJ, Dite GS, Milne RL, Liao Y, Zeinomar N, Knight JA, Southey MC, Vahdat L, Kornhauser N, Cigler T, Chung WK, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S; kConFab Investigators, Andrulis IL, Buys SS, Daly MB, Terry MB.

Breast Cancer Res. 2019 Apr 18;21(1):52. doi: 10.1186/s13058-019-1135-y.

2.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

3.

Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study.

Clarke CA, Canchola AJ, Moy LM, Neuhausen SL, Chung NT, Lacey JV Jr, Bernstein L.

Breast Cancer Res. 2017 May 1;19(1):52. doi: 10.1186/s13058-017-0840-7.

4.

Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.

Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR.

Breast Cancer Res Treat. 2011 Feb;126(1):149-55. doi: 10.1007/s10549-010-1074-x. Epub 2010 Jul 29.

5.
6.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

7.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

8.

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk.

Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI.

JAMA. 2004 May 26;291(20):2433-40.

PMID:
15161893
9.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.

Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE.

J Clin Oncol. 2012 Oct 1;30(28):3468-77. Epub 2012 Aug 27.

10.

Regular aspirin use and breast cancer risk in US Black women.

Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L.

Cancer Causes Control. 2011 Nov;22(11):1553-61. doi: 10.1007/s10552-011-9832-6. Epub 2011 Aug 30.

11.

Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.

Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):261-4.

12.

Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.

Brasky TM, Liu J, White E, Peters U, Potter JD, Walter RB, Baik CS, Lane DS, Manson JE, Vitolins MZ, Allison MA, Tang JY, Wactawski-Wende J.

Int J Cancer. 2014 Oct 15;135(8):1869-83. doi: 10.1002/ijc.28823. Epub 2014 Mar 20.

13.

Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer.

Kim S, Shore DL, Wilson LE, Sanniez EI, Kim JH, Taylor JA, Sandler DP.

BMC Cancer. 2015 Dec 16;15:960. doi: 10.1186/s12885-015-1979-1.

14.

Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.

Brasky TM, Moysich KB, Cohn DE, White E.

Gynecol Oncol. 2013 Jan;128(1):113-119. doi: 10.1016/j.ygyno.2012.10.005. Epub 2012 Oct 9.

15.

Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A; Women's Health Initiative.

Cancer Res. 2003 Sep 15;63(18):6096-101.

16.

Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT.

Epidemiology. 2016 Jul;27(4):586-93. doi: 10.1097/EDE.0000000000000480.

17.

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.

Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA.

Breast Cancer Res. 2008;10(2):R38. doi: 10.1186/bcr2089. Epub 2008 Apr 30.

18.

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.

PMID:
17551148
19.

Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort.

Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E.

Cancer Causes Control. 2012 Mar;23(3):431-44. doi: 10.1007/s10552-011-9891-8. Epub 2012 Jan 3.

20.

Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.

Merritt MA, Rice MS, Barnard ME, Hankinson SE, Matulonis UA, Poole EM, Tworoger SS.

Lancet Oncol. 2018 Aug;19(8):1107-1116. doi: 10.1016/S1470-2045(18)30373-5. Epub 2018 Jul 18.

Supplemental Content

Support Center